TIME logo
Connect Wallet
Wallet Settings
Disconnect Wallet
MetaMask
WalletConnect
Sign In
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
SUBSCRIBE FOR $19
Subscribe
Daily Spotlight
Can Birth Control Solve Rat Infestations?
Close
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
Sign In
Subscribe
Sections
Home
U.S.
Politics
World
Health
Climate
Future of Work by Charter
Business
Tech
Entertainment
Ideas
Science
History
Sports
Magazine
TIME 2030
TIME Studios
Video
TIME100 Talks
TIMEPieces
The TIME Vault
TIME for Health
TIME for Kids
TIME Edge
TIME CO2
Red Border: Branded Content by TIME
Join Us
Newsletters
Subscribe
Subscriber Benefits
Give a Gift
Shop the TIME Store
Connect Wallet
Customer Care
US & Canada
Global Help Center
Reach Out
Careers
Press Room
Contact the Editors
Media Kit
Reprints and Permissions
More
Privacy Policy
Your California Privacy Rights
Terms of Use
Site Map
Connect with Us
Drugs
Presented By
All Types of Hormonal Birth Control Share a Slightly Increased Risk of Breast Cancer
By Haley Weiss
Sanofi Becomes Third Insulin Producer to Cut Prices
By Ilena Peng/Bloomberg
Psychedelics Could Revolutionize Couples Therapy
By Jamie Ducharme
Novo Nordisk Plans Price Cuts for Insulins
By Associated Press
More in
Drugs
The VA Will Pay for Some to Get New Alzheimer’s Drug
It's a move toward broader coverage of the controversial drug category.
By John Tozzi and Robert Langreth/Bloomberg
March 13, 2023
FDA Approves a New Nasal Spray to Treat Migraines
The drug, zavegepant (brand name: Zavzpret), is the first of its type available in a nasal spray.
By Alice Park
March 10, 2023
Is the Marijuana Legalization Movement in Trouble?
Voters in Oklahoma resoundingly rejected a legalization measure on the ballot Tuesday—following rejections in 2022 in three other states
By Tara Law
March 8, 2023
Only Drug to Prevent Premature Births Will Be Pulled from U.S. Market
While the drug Makena won accelerated FDA approval in 2011, a study found it didn’t work better than older drugs.
By Michelle Fay Cortez/Bloomberg
March 8, 2023
How the Other Insulin Makers Are Responding to Eli Lilly’s Price Cap
Health policy experts say Eli Lilly's competitors are now facing increasing pressure to respond.
By Nik Popli
March 2, 2023
Ozempic's Popularity Is Triggering People with Eating Disorders
'I don't need to read more gory details.'
By Jamie Ducharme
March 2, 2023
FDA Panel Backs GSK’s RSV Vaccine for Older People
The drugmaker is racing against Pfizer Inc. to bring to market the first vaccine for RSV.
By Lisa Pham and Tanaz Meghjani/Bloomberg
March 2, 2023
FDA Panel Narrowly Backs Pfizer RSV Vaccine for Older Adults
The FDA panel voted on whether Pfizer's data showed the vaccine was safe and effective against the respiratory virus for people 60 and up.
By Matthew Perrone/AP
March 1, 2023
Eli Lilly Plans To Slash Some Insulin Prices and Expand Cost Cap
The moves promise relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
By Tom Murphy/AP
March 1, 2023
A New Alzheimer's Drug Gave Patients Hope. Millions Can't Get It
An unusual Medicare reimbursement policy means that promising new drugs for Alzheimer's, like Leqembi, are out of reach for most patients.
By Alice Park
February 10, 2023
Psychedelics May Be Part of U.S. Medicine Sooner Than You Think
Australian psychiatrists will soon be able to prescribe MDMA and psilocybin. The U.S. may not be too far behind.
By Jamie Ducharme
February 8, 2023
Eli Lilly's Alzheimer’s Drug Donanemab Fails to Get Early FDA Approval
In an unexpected setback for the drugmaker, Eli Lilly & Co.’s bid for accelerated approval of donanemab was rejected by U.S. regulators.
By Robert Langreth and Nacha Cattan/Bloomberg
January 20, 2023
FDA Approves Lecanemab, a New Alzheimer’s Drug
The drug could be the most effective yet to treat Alzheimer’s, but caution is warranted.
By Alice Park
January 6, 2023
Colorado Votes to Decriminalize Psychedelics
Colorado voters have approved the broadest psychedelic legalization in the U.S.
By Tara Law
November 11, 2022
Adderall Shortage Expected to Continue for Months in the U.S.
Teva Pharmaceutical Industries’ Adderall shortage is expected to last through March—which is longer than anticipated.
By Ike Swetlitz/Bloomberg
October 13, 2022
Why Overdose Deaths Have Increased
Opioid prescriptions have dropped in every state over the last decade, but the effort to prevent overdose deaths is an abject failure
By Tara Law
September 19, 2022
What to Know About ‘Rainbow Fentanyl’
It's dangerous for teens, but experts say there are greater risks
By Tara Law
September 12, 2022
Taking Psychedelics Could Make People Less Afraid of Dying
New research found that psychedelics and near-death experiences both reduced anxiety about death
By Tara Law
August 26, 2022
Dying Patients Are Fighting for Access to Psychedelics
Advocates argue that terminal patients should be able to get psilocybin and MDMA through the Right to Try law. Others want to expand access further.
By Tara Law
August 24, 2022
Here's What to Know About Narcan and Naloxone
Carrying Narcan can save someone who's overdosing on opioids.
By Tara Law
August 4, 2022
The Legal Challenges Around CBD for Cops
Using CBD risks testing positive for trace amounts of THC, the mind-altering compound in cannabis—a career-ender in most law enforcement agencies in the U.S.
By Katja Ridderbusch
July 29, 2022
Drug Overdose Deaths Rose More Among Black and Indigenous Americans During COVID-19 Pandemic
The increase was especially high for Black, American Indian, and Alaska Native people
By Tara Law
July 20, 2022
Michael Pollan on the Psychedelic Renaissance and Netflix's New 'How to Change Your Mind' Documentary
A Q&A with TIME
By Tara Law
July 12, 2022
The Economics of Legal Weed Don't Work
The legal cannabis business has been hampered by regulation and competition
By Belinda Luscombe
June 21, 2022
Melatonin Poisoning in Kids Is on the Rise: Study
The sleep aid is behind a huge number of childhood self-poisonings
By Jeffrey Kluger
June 3, 2022
Biogen's Controversial Alzheimer’s Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study Data
Biogen presented its complete findings on aduhelm, the first drug approved to treat Alzheimer’s disease. Doctors are still skeptical
By Alice Park
November 12, 2021
Clinics Won't Provide It. Insurers Won't Cover It. So Will the First Alzheimer's Drug Make a Difference?
The FDA approved the first treatment for the memory disorder, but it won’t be easy for patients to get it
By Alice Park and Tara Law
August 5, 2021
Supreme Court Rules On Crack Cocaine Sentencing Case
On Monday, the U.S. Supreme Court unanimously ruled that people imprisoned for possessing small amounts of crack cocaine before 2010 are not eligible for reduced sentences under the 2018 First Step Act. The case, Terry...
By Madeleine Carlisle
May 3, 2021
Inside Ibogaine: A Promising Drug for Addiction
Derived from the root bark of an African shrub, Ibogaine was ignored in modern medicine until recently
By Mandy Oaklander
April 5, 2021
How Methamphetamine Became a Key Part of Nazi Military Strategy
World War II was not only the most destructive war in human history but also the most pharmacologically enhanced. It was literally sped up by speed
By Peter Andreas
January 7, 2020
Low-Dose Aspirin May Not Reduce Heart Risks for Black Americans, Study Finds
But that doesn't mean that African-Americans should avoid it
By Alice Park
December 11, 2019
Google Honors Pioneering Psychiatrist Herb Kleber, Who Treated Addiction as a Disease, Not a Moral Failing
Dr. Herbert Kleber, one of the first major researchers to treat addiction as a disease, not a moral failing, is remembered by Google Doodle on the 23rd anniversary of his election to the National Academy...
By Gina Martinez
October 1, 2019
Trump Urges USPS and FedEx to Crackdown on Fentanyl Trafficking From China. They've Been Trying for Years
American officials have long blamed China for the influx of fentanyl reaching U.S. borders
By Sanya Mansoor
August 24, 2019
More Than $1 Million in Cocaine Found in Banana Shipments
The contraband was found stashed with ordinary produce at three Safeway grocery stores in Washington state
By Hillary Leung
August 22, 2019
Nearly 4 Tons of Marijuana Found Hidden in Jalapeño Peppers Seized in San Diego
Border Patrol agents on Thursday discovered nearly four tons of marijuana hidden in a shipment of jalapeño peppers traveling from Mexico to the US, officials said. The discovery was made at the Otay Mesa border...
By Julia Webster
August 19, 2019
America's War on Drugs Has Treated People Unequally Since Its Beginning
As difficult as passing drug laws is, enforcing them effectively, consistently and fairly has proven to be virtually impossible
By John H. Halpern and David Blistein
August 12, 2019
Tennessee Police Warnings of 'Meth Gators' Just A Joke
Tennessee police asked the public to abstain from flushing drugs
By Amy Gunia
July 16, 2019
Despite the Headlines, We Don't Yet Know If Anticholinergic Drugs Contribute to Dementia Risk
A large study found a link between certain widely used anticholinergic drugs and a higher risk of dementia. But that doesn’t mean people should stop taking them
By Alice Park
June 26, 2019
The New 'Female Viagra' Has Reignited a Debate Over Drugs and Female Sexuality
Some experts don't think they work
By Jamie Ducharme
June 25, 2019
A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating a Whole New Headache
Last May, the Food and Drug Administration (FDA) approved Amgen and Novartis' Aimovig, the first drug specifically designed to prevent chronic migraines, and offered new hope to the millions of Americans regularly weathering these debilitating...
By Jamie Ducharme
June 24, 2019
16 Tons of Cocaine Seized in Philadelphia Port
Federal officials estimate the street value at over $1 billion
By Jasmine Aguilera
June 18, 2019
Why TV Ads for Drugs Must Now Include Prices
Drug companies will soon be required to include their prices in television ads, in an effort to drive down costs and boost transparency.
By Jamie Ducharme
May 9, 2019
Denver Approves Decriminalizing Psilocybin Mushrooms in Unofficial Results, as Public Support for Psychedelic Drug Research Grows
The measure appeared to be defeated on the night of the ballot
By Jamie Ducharme
May 8, 2019
Are Sleeping Pills Safe? Here's What Research Says
The FDA is strengthening its warnings
By Jamie Ducharme
May 7, 2019
Study Finds Sunscreen Ingredients Absorb Into Blood
An FDA study found that active ingredients can pass into the bloodstream
By Alice Park
May 6, 2019
The FDA Just Approved the First Generic Nasal Spray to Reverse Opioid Overdoses
There will now be a generic alternative to Narcan
By Jamie Ducharme
April 19, 2019
Load More Articles
More from
TIME
More From TIME
